Is your employer dropping GLP-1 coverage in 2027? You are not imagining the trend. As open enrollment packets land this fall, a growing number of companies are quietly removing Wegovy, Zepbound, and other weight-management GLP-1s from their plans for next year. The good news: you have several weeks to prepare, and the steps below can save you hundreds of dollars a month.
Why employers are dropping GLP-1 coverage in 2027
The numbers behind the headlines come from two big employer surveys. In the Business Group on Health 2026 survey, 67% of large employers currently cover GLP-1s for weight management. However, only 72% of those say they are likely to keep that coverage in 2027, and 10% say they likely will not. Nearly eight in ten report that GLP-1s are pushing their health-care costs up.
Mercer’s survey of large employers (500+ workers) tells a similar story: roughly 5% plan to eliminate the weight-loss benefit next year, and many more are adding hurdles instead of cutting coverage outright. Those hurdles include:
- Requiring a BMI or other biometric proof of clinical eligibility before approval.
- Requiring you to enroll in a lifestyle or weight-management program to keep coverage.
- Limiting which providers can prescribe, or which drugs stay on the formulary.
- Higher copays, new prior authorizations, or annual reauthorization.
In other words, “dropping coverage” is a spectrum. Some people will lose the benefit entirely, while others will keep it with new strings attached. Your first job is to figure out which situation you are in.
Step 1: Read your 2027 plan documents carefully
Open enrollment usually runs from mid-October through November. Before it starts, HR posts a Summary of Benefits and Coverage (SBC) and a drug formulary for each plan. Search those documents for the terms “GLP-1,” “weight management,” “anti-obesity,” and the brand names you take. Then check three things:
- Is the drug still on the formulary? If Zepbound or Wegovy is missing, coverage for weight loss is likely gone. Note that GLP-1s prescribed for type 2 diabetes (Ozempic, Mounjaro) are usually still covered.
- Which tier is it on? A jump from tier 2 to tier 4 can raise your copay from $25 to hundreds of dollars.
- Are there new requirements? Look for prior authorization, step therapy, program participation, or BMI thresholds.
If anything is unclear, call the pharmacy benefit manager (the number on the back of your card) and ask directly: “Will [drug] be covered for weight management on January 1, 2027, and what do I need to do to qualify?” Write down the date, the representative’s name, and the answer.
Step 2: Compare plan options during open enrollment
An employer dropping GLP-1 coverage on one plan does not always drop it on every plan. If your company offers more than one option, coverage can differ between them. A higher-premium PPO may keep GLP-1s while the high-deductible plan does not, or vice versa. Do the math for the whole year, not just the premium: add premiums, the deductible you are likely to hit, and your estimated monthly drug cost under each plan. A free GLP-1 cost calculator makes it quick to compare scenarios side by side.
Also check a spouse’s or partner’s plan if you have one. Family coverage on a plan that includes GLP-1s can be cheaper than self-pay, even with a higher premium.
Step 3: Know your self-pay prices before you need them
If your employer is dropping GLP-1 coverage and no other plan is available, self-pay is more affordable than it was even a year ago. As of September 2026, manufacturer direct-to-consumer programs list roughly these prices (always confirm current pricing before you buy):
- Zepbound vials (LillyDirect): about $299/month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg and above when refilled within 45 days.
- Wegovy pen (NovoCare / TrumpRx): $199/month for the first two starter fills for new self-pay patients through December 31, 2026, then about $349/month for most doses.
- Wegovy pill: roughly $149 to $299/month depending on dose.
Those numbers are for U.S. residents paying cash, and they exclude anyone using government programs. If you are on Medicare, read our guide to Medicare GLP-1 coverage and the $50 copay instead. For a fuller breakdown of every option, see what GLP-1s really cost in 2026.
Step 4: Talk to your prescriber before January
Losing coverage does not have to mean stopping cold. Bring your prescriber into the conversation in November or December so you have a plan in place before the switch. Questions worth asking:
- If I move to self-pay, is a vial or pen version cheaper at my dose?
- Would a different medication in the same class be covered or less expensive?
- Can I stay at my current dose, or is a lower maintenance dose reasonable for me?
- What is the right way to taper if I decide to pause?
Switching products or doses is exactly when logging matters most, because your side effects and hunger can shift for a few weeks. Keeping every dose, weight, and symptom in one place with a free tracker like Pep gives you and your prescriber a clear picture to work from, and Pep’s built-in cost log shows what the change is really costing you month to month.
Step 5: Use the last months of coverage wisely
While your 2026 benefits are still active, a few moves can stretch them:
- Refill on schedule. Fill every eligible refill through December so you start January with medication on hand. Do not stockpile beyond what the plan allows.
- Get a fresh prescription. A current prescription makes it easy to enroll in a manufacturer self-pay program on day one.
- Ask about appeals. If your plan keeps GLP-1s only for certain conditions (sleep apnea, heart disease, diabetes), your prescriber may be able to document a qualifying diagnosis.
- Check your FSA or HSA elections. Self-pay GLP-1s are generally an eligible medical expense, so set aside pre-tax dollars during open enrollment.
Coverage can also come back. Several pharmacy benefit managers have already reversed earlier restrictions, as we covered when CVS Caremark restored Zepbound coverage. Keep your dose history intact so restarting a covered product later is simple.
Employer dropping GLP-1 coverage: FAQ
Can my employer legally drop GLP-1 coverage for weight loss?
Yes. Employer plans are not required to cover anti-obesity medications, so companies can add or remove them each plan year. Coverage for diabetes is handled differently and is much more likely to continue.
Will I lose coverage mid-year, or only at renewal?
Most changes take effect on the plan’s renewal date, typically January 1. Some plans do make mid-year formulary changes, but they must notify you in advance. Watch for letters from your pharmacy benefit manager.
What if my employer is dropping GLP-1 coverage but I have a medical need?
Ask your prescriber about a formulary exception or an appeal with documentation of your diagnosis and progress. Even when weight-management coverage is cut, plans often still cover GLP-1s for type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea.
Download Pep free — track your shots, pills & progress in one app.
This article is for educational purposes only and is not medical, legal, or insurance advice. Talk with your prescriber and your benefits administrator about your specific situation.